c2c12 myoblast cell line Search Results


99
ATCC c2c12 subclone
C2c12 Subclone, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2c12 subclone/product/ATCC
Average 99 stars, based on 1 article reviews
c2c12 subclone - by Bioz Stars, 2025-03
99/100 stars
  Buy from Supplier

97
ATCC mouse myoblast cell line c2c12
Mouse Myoblast Cell Line C2c12, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse myoblast cell line c2c12/product/ATCC
Average 97 stars, based on 1 article reviews
mouse myoblast cell line c2c12 - by Bioz Stars, 2025-03
97/100 stars
  Buy from Supplier

97
ATCC mouse muscle cell lines
Mouse Muscle Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse muscle cell lines/product/ATCC
Average 97 stars, based on 1 article reviews
mouse muscle cell lines - by Bioz Stars, 2025-03
97/100 stars
  Buy from Supplier

86
Thermo Fisher c2c12 myoblasts
(A) Relative VEGF mRNA expression in HUVEC 2d after transfection with HIF1α siRNA or control scrambled (Sble) siRNA and cultured in control (Ctrl) or SAA deficient (-M&C) media for 16hr; n=5 experiments/group; error bars indicate SEM. (B) Immunoblots of HIF1α, eIF2α (p- Ser51, total) and ATF4 in HUVEC cultured as indicated for 16hr. (C) Relative VEGF mRNA expression in HUVEC 2d after transfection with ATF4 or Sble siRNA and cultured as indicated for 16hr; n=4 experiments/group; SEM. (D, E) Relative HUVEC VEGF mRNA expression (D, n=3 experiments/group; SEM) and secreted VEGF protein concentration in media (E, n=3–6 experiments/group; SEM) 2d after transfection with ATF4 overexpression (ATF4OE) or control construct (Empty). (F, G) VEGF mRNA expression (F) and spheroid formation (G) in WT and GCN2KO primary mouse EC from n=3 mice/genotype cultured as indicated for 16hr. For sprouting assay (G), representative images (left, 40X mag) and quantification (right) of WT and GCN2KO EC spheroids cultured in the indicated media for 24hr; blue, DNA (DAPI); red, F-actin (phalloidin). (H) Representative transverse sections (left, 40X mag) and quantification (right) of CD31-stained gastroc in WT or GCN2KO mice fed for 2–4wk on Ctrl or MR diets; n=5–6 mice/group. (I) VEGF mRNA in MDF, MEF or <t>C2C12</t> myotubes cultured as indicated for 16hr; n=4–6 experiments/group; SEM. (J) VEGF mRNA expression in WT and GCN2KO primary mouse skeletal myotubes (n=5 mice/genotype tested at 2 different passages) cultured as indicated for 16hr. (K) Immunoblots of HIF1α, PGC1α, eIF2α (p-Ser51, total) and ATF4 in C2C12 myotubes cultured as indicated for 16hr. Error bars indicate SD unless otherwise noted; asterisks indicate the significance of the difference by Student’s T test or 1-way ANOVA with Sidak’s MCT between diets in vivo or SAA deprivation in vitro; *P<0.05, **P<0.01, ***P<0.001. See also Fig. S2.
C2c12 Myoblasts, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2c12 myoblasts/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
c2c12 myoblasts - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier

86
Amaxa c2c12 myoblast
(A) Relative VEGF mRNA expression in HUVEC 2d after transfection with HIF1α siRNA or control scrambled (Sble) siRNA and cultured in control (Ctrl) or SAA deficient (-M&C) media for 16hr; n=5 experiments/group; error bars indicate SEM. (B) Immunoblots of HIF1α, eIF2α (p- Ser51, total) and ATF4 in HUVEC cultured as indicated for 16hr. (C) Relative VEGF mRNA expression in HUVEC 2d after transfection with ATF4 or Sble siRNA and cultured as indicated for 16hr; n=4 experiments/group; SEM. (D, E) Relative HUVEC VEGF mRNA expression (D, n=3 experiments/group; SEM) and secreted VEGF protein concentration in media (E, n=3–6 experiments/group; SEM) 2d after transfection with ATF4 overexpression (ATF4OE) or control construct (Empty). (F, G) VEGF mRNA expression (F) and spheroid formation (G) in WT and GCN2KO primary mouse EC from n=3 mice/genotype cultured as indicated for 16hr. For sprouting assay (G), representative images (left, 40X mag) and quantification (right) of WT and GCN2KO EC spheroids cultured in the indicated media for 24hr; blue, DNA (DAPI); red, F-actin (phalloidin). (H) Representative transverse sections (left, 40X mag) and quantification (right) of CD31-stained gastroc in WT or GCN2KO mice fed for 2–4wk on Ctrl or MR diets; n=5–6 mice/group. (I) VEGF mRNA in MDF, MEF or <t>C2C12</t> myotubes cultured as indicated for 16hr; n=4–6 experiments/group; SEM. (J) VEGF mRNA expression in WT and GCN2KO primary mouse skeletal myotubes (n=5 mice/genotype tested at 2 different passages) cultured as indicated for 16hr. (K) Immunoblots of HIF1α, PGC1α, eIF2α (p-Ser51, total) and ATF4 in C2C12 myotubes cultured as indicated for 16hr. Error bars indicate SD unless otherwise noted; asterisks indicate the significance of the difference by Student’s T test or 1-way ANOVA with Sidak’s MCT between diets in vivo or SAA deprivation in vitro; *P<0.05, **P<0.01, ***P<0.001. See also Fig. S2.
C2c12 Myoblast, supplied by Amaxa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2c12 myoblast/product/Amaxa
Average 86 stars, based on 1 article reviews
c2c12 myoblast - by Bioz Stars, 2025-03
86/100 stars
  Buy from Supplier

Image Search Results


(A) Relative VEGF mRNA expression in HUVEC 2d after transfection with HIF1α siRNA or control scrambled (Sble) siRNA and cultured in control (Ctrl) or SAA deficient (-M&C) media for 16hr; n=5 experiments/group; error bars indicate SEM. (B) Immunoblots of HIF1α, eIF2α (p- Ser51, total) and ATF4 in HUVEC cultured as indicated for 16hr. (C) Relative VEGF mRNA expression in HUVEC 2d after transfection with ATF4 or Sble siRNA and cultured as indicated for 16hr; n=4 experiments/group; SEM. (D, E) Relative HUVEC VEGF mRNA expression (D, n=3 experiments/group; SEM) and secreted VEGF protein concentration in media (E, n=3–6 experiments/group; SEM) 2d after transfection with ATF4 overexpression (ATF4OE) or control construct (Empty). (F, G) VEGF mRNA expression (F) and spheroid formation (G) in WT and GCN2KO primary mouse EC from n=3 mice/genotype cultured as indicated for 16hr. For sprouting assay (G), representative images (left, 40X mag) and quantification (right) of WT and GCN2KO EC spheroids cultured in the indicated media for 24hr; blue, DNA (DAPI); red, F-actin (phalloidin). (H) Representative transverse sections (left, 40X mag) and quantification (right) of CD31-stained gastroc in WT or GCN2KO mice fed for 2–4wk on Ctrl or MR diets; n=5–6 mice/group. (I) VEGF mRNA in MDF, MEF or C2C12 myotubes cultured as indicated for 16hr; n=4–6 experiments/group; SEM. (J) VEGF mRNA expression in WT and GCN2KO primary mouse skeletal myotubes (n=5 mice/genotype tested at 2 different passages) cultured as indicated for 16hr. (K) Immunoblots of HIF1α, PGC1α, eIF2α (p-Ser51, total) and ATF4 in C2C12 myotubes cultured as indicated for 16hr. Error bars indicate SD unless otherwise noted; asterisks indicate the significance of the difference by Student’s T test or 1-way ANOVA with Sidak’s MCT between diets in vivo or SAA deprivation in vitro; *P<0.05, **P<0.01, ***P<0.001. See also Fig. S2.

Journal: Cell

Article Title: Amino acid restriction triggers angiogenesis via GCN2/ATF4 regulation of VEGF and H 2 S production

doi: 10.1016/j.cell.2018.03.001

Figure Lengend Snippet: (A) Relative VEGF mRNA expression in HUVEC 2d after transfection with HIF1α siRNA or control scrambled (Sble) siRNA and cultured in control (Ctrl) or SAA deficient (-M&C) media for 16hr; n=5 experiments/group; error bars indicate SEM. (B) Immunoblots of HIF1α, eIF2α (p- Ser51, total) and ATF4 in HUVEC cultured as indicated for 16hr. (C) Relative VEGF mRNA expression in HUVEC 2d after transfection with ATF4 or Sble siRNA and cultured as indicated for 16hr; n=4 experiments/group; SEM. (D, E) Relative HUVEC VEGF mRNA expression (D, n=3 experiments/group; SEM) and secreted VEGF protein concentration in media (E, n=3–6 experiments/group; SEM) 2d after transfection with ATF4 overexpression (ATF4OE) or control construct (Empty). (F, G) VEGF mRNA expression (F) and spheroid formation (G) in WT and GCN2KO primary mouse EC from n=3 mice/genotype cultured as indicated for 16hr. For sprouting assay (G), representative images (left, 40X mag) and quantification (right) of WT and GCN2KO EC spheroids cultured in the indicated media for 24hr; blue, DNA (DAPI); red, F-actin (phalloidin). (H) Representative transverse sections (left, 40X mag) and quantification (right) of CD31-stained gastroc in WT or GCN2KO mice fed for 2–4wk on Ctrl or MR diets; n=5–6 mice/group. (I) VEGF mRNA in MDF, MEF or C2C12 myotubes cultured as indicated for 16hr; n=4–6 experiments/group; SEM. (J) VEGF mRNA expression in WT and GCN2KO primary mouse skeletal myotubes (n=5 mice/genotype tested at 2 different passages) cultured as indicated for 16hr. (K) Immunoblots of HIF1α, PGC1α, eIF2α (p-Ser51, total) and ATF4 in C2C12 myotubes cultured as indicated for 16hr. Error bars indicate SD unless otherwise noted; asterisks indicate the significance of the difference by Student’s T test or 1-way ANOVA with Sidak’s MCT between diets in vivo or SAA deprivation in vitro; *P<0.05, **P<0.01, ***P<0.001. See also Fig. S2.

Article Snippet: Genetic manipulations in cultured cells siRNA knockdown siRNA knockdown of human activating transcription factor 4 (ATF4), human endothelial nitric oxide synthase (eNOS), human hypoxia-inducible factor 1-α (HIF1α), PGC1α (PPARGC1A) in HUVEC as well as mouse HIF1α and PGC1α in C2C12 myoblasts was performed using lipofectamine RNAiMAX (Life Technologies) and 30nM siRNA purchased from Ambion (Ambion, ThermoFisher) as described previously ( Hine et al., 2015 ).

Techniques: Expressing, Transfection, Cell Culture, Western Blot, Protein Concentration, Over Expression, Construct, Staining, In Vivo, In Vitro

KEY RESOURCES TABLE

Journal: Cell

Article Title: Amino acid restriction triggers angiogenesis via GCN2/ATF4 regulation of VEGF and H 2 S production

doi: 10.1016/j.cell.2018.03.001

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Genetic manipulations in cultured cells siRNA knockdown siRNA knockdown of human activating transcription factor 4 (ATF4), human endothelial nitric oxide synthase (eNOS), human hypoxia-inducible factor 1-α (HIF1α), PGC1α (PPARGC1A) in HUVEC as well as mouse HIF1α and PGC1α in C2C12 myoblasts was performed using lipofectamine RNAiMAX (Life Technologies) and 30nM siRNA purchased from Ambion (Ambion, ThermoFisher) as described previously ( Hine et al., 2015 ).

Techniques: Plasmid Preparation, Recombinant, Lysis, Enzyme-linked Immunosorbent Assay, Isolation, Negative Control, Over Expression, Software